DUBLIN–(BUSINESS WIRE)–The “Cell Line and Membrane Market By Products, By Source, By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.
The global cell line and membrane market was valued at $4,533.04 million in 2021, and is projected to reach $10,574.56 million by 2031, registering a CAGR of 8.8% from 2022 to 2031.
A cell line is a permanently established cell culture that will multiply indefinitely in a given appropriate fresh medium and space and is frequently used to investigate biological processes in place of primary cells. Transfection, selection, and single-cell cloning are all a part of the cell line generation process.
Various types of cells are used to create different cell lines. Cell lines allow for the gradual changes in cell structure, physiology, and genetic makeup in a controlled setting.. Cell lines are derived from single cells and are used to make fusion proteins, monoclonal antibodies, and vaccines.
Cell lines have revolutionized scientific research and they are widely used in the production of vaccines, testing drug metabolisms & cytotoxicity, antibody production, study of gene function, generation of artificial tissues (artificial skin), and synthesis of biological compounds (therapeutic proteins).
The key factors that drive the growth of market are rise in the prevalence of cancer & chronic diseases, rise in geriatric population, and an increase in vaccine production. In addition, the rise in novel drug development activities, growth in use of mammalian cell for cell line production, and surge in technological advancements in expression vector design are the key factors that boost the market growth. For instance, according to the International Agency of Cancer Research, 9,503,710 new cancer cases were diagnosed in Asia in 2020.
However, the strict regulatory framework coupled with the time-consuming process for the development of stable lines hampers the market growth. Conversely, emerging healthcare market in developing countries & low-income countries and increase in the risk of pandemic & communicable diseases are expected to provide lucrative opportunity for the growth of market during the forecast period.
North America accounted for a majority of the cell line and membrane market share in 2021 and is anticipated to remain dominant during the forecast period owing to rise in the prevalence of cancer, increased use of media & reagents for cell line development, and presence of major key players in the region.
Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rise in prevalence of chronic diseases and increase in geriatric population in developing countries.
The key players that operate in the cell line and membrane market are Advanced Instruments LLC, AGC Biologics, Cytiva Lifesciences, Sartorius Cellgenix Gmbh, Premas Biotech, Selexis SA, Lonza, Samsung Biologics, PromoCell, Thermofisher Scientific Inc, Imegenex India Pvt. Ltd., and ProBioGen.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell line and membrane market analysis from 2021 to 2031 to identify the prevailing cell line and membrane market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cell line and membrane market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cell line and membrane market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Products
- Media and Reagents
- Type
- Serum
- Media
- Reagents
- Equipments
- Type
- Biosafety Cabinets
- Cell Counters and Viability Systems
- Incubators
- Centrifuges
- Bioreactors
- Storage Equipment
- Others
- Accessories and Consumables
By Source
- Non Mammalian Cell Line
- Type
- Insects
- Amphibians
- Mammalian Cell Line
By Type
- Hybridomas
- Continuous cell lines
- Recombinant cell lines
- Primary cell lines
By End User
- Biotechnology and Pharmaceutical Industries
- Academic and Research Institutes
- Others
Key Market Players
- Advanced Instruments LLC
- AGC Biologics
- Cytiva Lifesciences
- Sartorius
- Cellgenix Gmbh
- Premas Biotech
- Selexis SA
- Samsung Biologics
- Lonza
- Thermofisher Scientific Inc
- PromoCell
- ProBioGen
Key Topics Covered:
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CELL LINE AND MEMBRANE MARKET, BY PRODUCTS
CHAPTER 5: CELL LINE AND MEMBRANE MARKET, BY SOURCE
CHAPTER 6: CELL LINE AND MEMBRANE MARKET, BY TYPE
CHAPTER 7: CELL LINE AND MEMBRANE MARKET, BY END USER
CHAPTER 8: CELL LINE AND MEMBRANE MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
For more information about this report visit https://www.researchandmarkets.com/r/tjrta5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900